Prospective study sorafenib therapy advanced hepatocellular carcinoma patients
Latest Information Update: 18 Jun 2020
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
Most Recent Events
- 31 May 2020 Results testing hypothesis whether HCC patients with CTP-A class treated with sorafenib, those reclassified as IGF-CTP-B/C will have poorer prognosis in terms of shorter OS and PFS, presented at the 56th Annual Meeting of the American Society of Clinical Oncology
- 20 Feb 2019 New trial record
- 19 Jan 2019 Results presented at the 2019 Gastrointestinal Cancers Symposium